Skip to main content

Table 1 Concentrations of measured biomarkers during the pre-implantation (n = 125) and post-implantation (n  = 121) early pregnancy windows

From: Association of urinary concentrations of early pregnancy phthalate metabolites and bisphenol A with length of gestation

Biomarkera

Pre-implantation (n = 125)

Post-implantation (n = 121)b

Median

(IQR)

Median

(IQR)

MBP

58.7

(42.2, 85.6)

54.5

(37.2, 82.9)

MEP

105.4

(56.6, 234.1)

92.5

(53.6, 146.3)

MBzP

34.1

(20.3, 48.8)

25.3

(17.5, 39.4)

MEHP

5.3

(3.3, 7.8)

5.4

(3.3, 8.3)

MEHHP

36.0

(27.9, 55.2)

32.8

(24.2, 48.3)

MEOHP

23.2

(17.8, 31.6)

22.4

(16.2, 32.4)

MECPP

50.2

(39.4, 69.6)

48.1

(37.8, 68.4)

MCNP

2.8

(1.9, 4.5)

3.2

(2.2, 5.7)

MCOP

2.6

(1.9, 3.6)

2.0

(1.4, 2.8)

MCPP

10.5

(7.9, 14.7)

9.9

(6.9, 14.0)

MiBP

2.3

(1.7, 3.6)

2.0

(1.3, 2.8)

∑DEHPc

0.4

(0.3, 0.5)

0.4

(0.3, 0.5)

BPA

2.0

(1.4, 3.0)

1.8

(1.1, 2.6)

  1. aCreatinine adjusted (ng/mg creatinine).
  2. bFour women did not have post-implantation early pregnancy samples.
  3. c∑DEHP represents the molar sum of 4 metabolites of DEHP: MEHP, MEHHP, MEOHP, and MECPP creatinine adjusted (nmol/mg creatinine).